$138.0 Million
OptiNose AS
Initial Public Offering
Active Bookrunner
$136.9 Million
Menlo Therapeutics Inc.
Initial Public Offering
Active Bookrunner
$107.5 Million
Neuronetics, Inc.
Initial Public Offering
Active Bookrunner
$46.0 Million
Arsanis Inc.
Initial Public Offering
Passive Bookrunner
$138.8 Million
Deciphera Pharmaceuticals, Inc.
Initial Public Offering
Active Bookrunner
$42.2 Million
ASLAN Pharmaceuticals Pte. Ltd.
Initial Public Offering
Active Bookrunner
$76.3 Million
Ra Medical Systems Inc.
Initial Public Offering
Left Bookrunner
$85.0 Million
Sutro Biopharma, Inc.
Initial Public Offering
Active Bookrunner
$143.8 Million
Paragon 28, Inc.
Initial Public Offering
Active Bookrunner
$377.3 Million
Oak Street Health, Inc
Initial Public Offering
Passive Bookrunner
Subscribe to IPO

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.